Vermaak W J, Barnard H C, van Dalen E M, Potgieter G M
Enzyme. 1986;35(4):215-24. doi: 10.1159/000469345.
Conflicting results using erythrocyte aminotransferase (eAST) stimulation to assess vitamin B6 nutritional status in patients with less severe B6 deficiencies are common. It has been claimed that the presence of different B6 vitamers may modify the activation of eAST by pyridoxal-5'-phosphate (PLP) leading to stimulatory or even inhibitory effects. To investigate the possible role of this phenomenon in producing inconsistent AST stimulations, aliquots of whole blood were incubated with equivalent amounts of different B6 vitamers, and the AST stimulation was correlated with the concentrations of PLP, measured by high-performance liquid chromatography. At the end of the incubation period the erythrocytes and plasma were separately analyzed. The conversion of non-PLP B6 vitamers to PLP, by the erythrocytes, was similar (approximately 70%) for all B6 vitamers used in the incubation experiments. The newly formed PLP accumulated in the erythrocytes, but the percentage activation of AST did not change significantly from the basal levels, in spite of the presence of increased levels of PLP and other B6 vitamers used for incubation. When PLP was used in the incubation studies, all of it was retained by the plasma and was associated with a marked suppression of plasma AST stimulation. To determine the degree to which plasma and erythrocyte AST was dose-dependent, plasma and haemolysates were incubated with increasing concentrations of PLP. A very significant inverse relationship was obtained in plasma between AST stimulation and PLP even at modest PLP levels, while haemolysates required incubation with much higher PLP concentrations to demonstrate the same effect. Since plasma PLP is considered to be the most reliable indicator of B6 nutritional status in man, our findings suggest that plasma percentage AST stimulation more closely reflects the B6 nutritional status than erythrocyte AST stimulation test which may reflect B6 status only in severe, longstanding B6 deficiencies. Conflicting results using erythrocyte AST stimulations may be attributed to the insensitivity of red cell AST to changes in PLP content. It is unlikely that the presence of non-PLP B6 vitamers in haemolysate may affect the percentage stimulation of aminotransferase enzymes by PLP.
在不太严重的维生素B6缺乏患者中,使用红细胞转氨酶(eAST)刺激来评估维生素B6营养状况时,结果相互矛盾的情况很常见。据称,不同维生素B6异构体的存在可能会改变磷酸吡哆醛(PLP)对eAST的激活作用,从而产生刺激甚至抑制作用。为了研究这种现象在导致AST刺激结果不一致方面可能起的作用,将全血 aliquots 与等量的不同维生素B6异构体一起孵育,并将AST刺激与通过高效液相色谱法测量的PLP浓度相关联。在孵育期结束时,分别分析红细胞和血浆。在孵育实验中使用的所有维生素B6异构体中,红细胞将非PLP维生素B6异构体转化为PLP的转化率相似(约70%)。新形成的PLP在红细胞中积累,但尽管存在增加水平的PLP和用于孵育的其他维生素B6异构体,AST的激活百分比与基础水平相比没有显著变化。当在孵育研究中使用PLP时,所有PLP都被血浆保留,并与血浆AST刺激的显著抑制相关。为了确定血浆和红细胞AST的剂量依赖性程度,将血浆和溶血产物与浓度不断增加的PLP一起孵育。即使在适度的PLP水平下,血浆中AST刺激与PLP之间也获得了非常显著的负相关关系,而溶血产物需要与高得多的PLP浓度孵育才能显示出相同的效果。由于血浆PLP被认为是人体维生素B6营养状况最可靠的指标,我们的研究结果表明,血浆AST刺激百分比比红细胞AST刺激试验更能密切反映维生素B6营养状况,红细胞AST刺激试验可能仅在严重、长期的维生素B6缺乏时反映维生素B6状况。使用红细胞AST刺激得到相互矛盾的结果可能归因于红细胞AST对PLP含量变化不敏感。溶血产物中存在非PLP维生素B6异构体不太可能影响PLP对转氨酶的刺激百分比。